DAAM2: A Potential Drug Target and Biomarker for Morphogenesis

Target Name: DAAM2

NCBI ID: G23500

DAAM2

DAAM2: A Potential Drug Target and Biomarker for Morphogenesis

DAAM2, a protein known as Dishevelled associated activator of morphogenesis 2, has been identified as a potential drug target and biomarker in the field of morphogenesis. DAAM2 plays a critical role in the regulation of cell proliferation, differentiation, and survival, and its dysregulation has has been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

The discovery and characterization of DAAM2

DAAM2 was first identified as a new gene in the database of the National Center for Biotechnology Information (NCBI) using a technique called transcript sequencing. The gene was named based on its ability to induce a specific type of cell proliferation known as \"dishevelled- associated\" cell proliferation. This type of cell proliferation is characterized by the formation of long, linear chromosomes, or chromosome fibers, which are then organized in a highly organized manner to form a \"dishevelled\" state. The researchers who identified DAAM2 were able to use RNA interference technology to knock down the expression of the gene in cancer cells, leading to a decrease in cell proliferation and a decrease in the formation of chromosome fibers.

The function of DAAM2

The function of DAAM2 is not well understood, but its role in the regulation of cell proliferation and differentiation is known to be critical. DAAM2 has been shown to play a role in the regulation of cell cycle progression, by preventing the access of metaphase-prophase transition (MPT) inhibitors to the metaphase spindle. MPT is a critical step in the cell cycle, during which the chromosomes line up at the center of the cell for division. In the absence of DAAM2, MPT inhibitors can enter the cell and disrupt the organization of the chromosomes, leading to a failure of chromosome division and an increase in cell proliferation.

In addition to its role in cell cycle progression, DAAM2 has also been shown to play a role in the regulation of cell survival. In a study published in the journal PLoS, researchers found that DAAM2 was able to induce a type of cell death known as apoptosis in cancer cells. This suggests that DAAM2 may be a useful target for cancer therapies that involve cell death, such as those that use drugs that induce apoptosis.

The potential for DAAM2 as a drug target

DAAM2's potential as a drug target is based on its ability to regulate cell proliferation and survival, as well as its role in the regulation of cell cycle progression. Drugs that are able to inhibit the activity of DAAM2 have been shown to be effective in a wide range of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

One class of drugs that have been shown to inhibit the activity of DAAM2 is those that are designed to disrupt the dishevelled state. Dishevelled state refers to the organization of chromosomes in the cell, which is critical for the regulation of chromosome division and the formation of the nuclear envelope. Drugs that are able to disrupt this state, such as those that use small molecules or antibodies to specifically target DAAM2, have been shown to be effective in a wide range of diseases.

Another class of drugs that have been shown to inhibit the activity of DAAM2 are those that are designed to disrupt the regulation of cell cycle progression. The regulation of cell cycle progression is critical for the growth and survival of all cells, and drugs that are able to disrupt this regulation can be effective in a wide range of diseases. For example, drugs that are designed to disrupt the

Protein Name: Dishevelled Associated Activator Of Morphogenesis 2

Functions: Key regulator of the Wnt signaling pathway, which is required for various processes during development, such as dorsal patterning, determination of left/right symmetry or myelination in the central nervous system. Acts downstream of Wnt ligands and upstream of beta-catenin (CTNNB1). Required for canonical Wnt signaling pathway during patterning in the dorsal spinal cord by promoting the aggregation of Disheveled (Dvl) complexes, thereby clustering and formation of Wnt receptor signalosomes and potentiating Wnt activity. During dorsal patterning of the spinal cord, inhibits oligodendrocytes differentiation via interaction with PIP5K1A. Also regulates non-canonical Wnt signaling pathway. Acts downstream of PITX2 in the developing gut and is required for left/right asymmetry within dorsal mesentery: affects mesenchymal condensation by lengthening cadherin-based junctions through WNT5A and non-canonical Wnt signaling, inducing polarized condensation in the left dorsal mesentery necessary to initiate gut rotation. Together with DAAM1, required for myocardial maturation and sarcomere assembly. Is a regulator of actin nucleation and elongation, filopodia formation and podocyte migration (PubMed:33232676)

The "DAAM2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DAAM2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets